Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia | |
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA | |
Education on Actionable Biomarker and Genetic Testing in Cancer for the Advanced Practice Provider (APP) Release Date: | Education | Oncology | USA | |
Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) | Education | Oncology | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates Release Date: | Education | Vaccines | USA | |
Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China Release Date: | Research | Inflammation & Immunology | China | |
Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder Release Date: | Education | Internal Medicine | Japan | |
Interventional Research Studies with Elranatamab Release Date: | Research | Oncology | All | |
Research in Ulcerative Colitis (UC) 2024 Release Date: | Research | Inflammation & Immunology | Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey | |
Advances in the Management of Ulcerative Colitis (UC) Release Date: | Education | Inflammation & Immunology | All | |
Research in Ulcerative Colitis (UC) 2024 Release Date: | Research | Inflammation & Immunology | Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom | |
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Release Date: | Research | Oncology | USA | |
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma Release Date: | Education | Oncology | Japan | |
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia Release Date: | Research | Hospital | Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom | |
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States) Release Date: | Education | Rare Disease | All | |
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT) | Education | Oncology | USA |